Inclusion Criteria:  Patients treated with the GORE® VIABAHN® VBX Balloon Expandable Endoprosthesis as a Bridging Stent in conjunction with a branched/fenestrated stent graft to allow endovascular aneurysm repair from 01 July 2021 until 01 January 2017 Age ≥18 years at the time of implant Provision of informed consent by the patient or next of kin/legal representative (for deceased patients at registry entry, unless a waiver was granted), according to local regulations.  Exclusion Criteria:  Patient treated for ruptured aneurysm or who were otherwise hemodynamically unstable at the time of the procedure Patient treated for acute or sub-acute dissection, <90 days from onset of symptoms Patient treated using physician-modified endovascular grafts Patient treated with chimney, periscope octopus, sandwich technique At the time of treatment, patient had known coagulation disorders including hypercoagulability that were not amenable to treatment Patient was pregnant at the time of treatment. Participation in another drug or device investigational study within one year of device implant, that can confound the registry endpoints. Patient had known or suspected systemic infection (including treatment for mycotic aneurysm) at the time of implant.